Skip to content
Alkeus Pharmaceuticals

General Interest

Cambridge, MA; Cambridge, MAUnited States
Corporate
POSTED 16 OCT 2024
Apply Ask
Role
765 days opentrue age
Posted 16 Oct 2024
Pay
$58k–$138kno pay posted
Market p25–p75
$58k–$138k
Boston · n=965 · 365d to 19 Nov
CompanyAlkeus Pharmaceuticals →
2open roles
Opened · 30d
+0
Closed · 30d
−0
Signal
● Steady0 net
18d of snapshots · 30d window
Market
414,987open · Other
Opened · 7d
+44,59411% of open
All other
621,848open
All tracked boards · live 21 Nov · n=414,987

Alkeus Pharmaceuticals, Inc. is a clinical-stage biotech company focused on the development of innovative therapies to treat serious diseases of the eye with high unmet need. Based in Cambridge, Mass., Alkeus was founded in 2010, and since that time has been developing its lead compound, gildeuretinol acetate (ALK-001). Designated as a breakthrough therapy and granted orphan drug status by the U.S. Food and Drug Administration, gildeuretinol is being evaluated in multiple clinical trials for the treatment of Stargardt disease and geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness in the U.S.

We are looking for enthusiastic professionals who want to be at the forefront of our mission and make a significant impact on the growth and direction of Alkeus Pharmaceuticals.

We invite you to apply and submit your resume for general consideration.

#LI-DNI

Alkeus Pharmaceuticals, Inc. is an equal opportunity employer and considers all qualified applicants for employment without regard to any characteristic protected by applicable law. We participate in E-Verify and conduct background checks as a part of our employment process.

Source · Alkeus Pharmaceuticals First seen 4 NovOriginal ↗